Tian, Yun
Guo, Jiafan
Mao, Lipeng
Chen, Zhixi
Zhang, Xingwei
Li, Yangqiu
Zhang, Yikai
Zha, Xianfeng
Luo, Oscar Junhong http://orcid.org/0000-0002-1266-3069
Funding for this research was provided by:
National Natural Science Foundation of China (82350610280, 92370107, 82293632, 82400259)
China Postdoctoral Science Foundation (2021M701427, 2013M540685)
Pearl River S and T Nova Program of Guangzhou Municipality (2019QN01Y990)
Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515011034)
Article History
Received: 31 July 2024
Accepted: 30 September 2024
First Online: 8 October 2024
Declarations
:
: This study was approved by the Ethics Committee of the School of Medicine, Jinan University (Approval No. [2015] Ethics Approval Section 009). Title of the approved project: Reversal Regulation of TCR VβT Cell Clone Dysfunction Mediated by Immune Checkpoint Receptors in AML. Date of approval: 01 January, 2016.
: The consent for publication was acquired from patients/participants. All authors confirm their consent for publication.
: The authors declare that they have no competing interests.